Researchers find deadly prescription drug effects 6 years before FDA
...t Northwesterns Feinberg School of Medicine, and a hematologist and oncologist at Northwestern Memorial Hospital, found RADAR identified serious drug reactions six years earlier than the FDA and drug companies. RADARs proactive safety efforts and reports also were much more comprehensive than those from the FDA...Mayo Clinic -- Collaborating to move treatment research forward
... newly diagnosed," says S. Vincent Rajkumar, M.D., hematologist at Mayo Clinic in Rochester, Minn., and lead autho...(cousin) of thalidomide, says Martha Lacy, M.D., a hematologist at Mayo Clinic in Rochester. She presented the latest results of a Phase II Mayo Clinic trial testin...Mayo Clinic Cancer Center -- Working on the tough cases
...Hodgkin lymphoma. Lead researcher and Mayo Clinic hematologist Thomas Witzig, M.D., discussed the findings at the 2006 American Society of Hematology Annual Meeting in Orlando. "Patients with aggressive non-Hodgkin lymphoma who relapse after conventional therapy or stem cell replacement traditionally have a p...Mayo Clinic Cancer Center collaborating to find new tools to fight leukemia
...c leukemia (CLL). Lead researcher and Mayo Clinic hematologist Neil E. Kay, M.D., presented these findings at the 2006 American Society of Hematology Annual Meeting in Orlando. "Chronic lymphocytic leukemia is incurable, but continues to be made more manageable with the advent of powerful new chemoimmunothera...Mayo Clinic Cancer Center -- individualizing treatment for multiple myeloma patients
...s the study's lead author, Leif Bergsagel, M.D., a hematologist at Mayo Clinic Arizona. "We now have identified a group that will likely respond because these nine mutations seem to be present in at least 25 percent of newly diagnosed patients. "Now that we know the pathway the drug targets, and genetic mutatio...Mayo Clinic: New recommendations for use of bisphosphonates in treatment of multiple myeloma
...ety concerns," said Martha Lacy, M.D., Mayo Clinic hematologist and lead author of the statement. "These drugs ha...oncerns," said Vincent Rajkumar, M.D., Mayo Clinic hematologist and co-author. "These recommendations are the result of years of practical knowledge combined by ou...New infectious agents pose new risks for people with bleeding disorders, Jefferson hematologist says
An international team of scientists, including a hematologist from Thomas Jefferson University in Philadelphia, ...n. Writing January 21, 2006 in the journal Lancet, hematologist Jamie Siegel, M.D., clinical associate professor of medicine at Jefferson Medical College of Thomas ...Mayo clinic reports some chronic leukemia patients may improve by taking an extract of green tea
...s disease," says Tait Shanafelt, M.D., Mayo Clinic hematologist and lead author of the article. Despite these encouraging preliminary findings, he urges caution. "We do not know how many patients were taking similar products and failed to have any benefit. We also do not yet know the optimal dose that should b...